Paper Details

  1. Home
  2. Paper Details

The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.

Author: BoggsRobert, MillerChristopher, MurphyKevin, NelsonHarold, O'DowdLiza, ParasuramanBhash

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Budesonide/formoterol pMDI significantly improved asthma-related quality of life, sleep quality, and asthma control compared to placebo. It also demonstrated greater satisfaction with treatment than other treatment groups.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To determine the effects of budesonide and formoterol administered via one pressurized metered-dose inhaler (budesonide/formoterol pMDI) on patient-reported outcomes (PROs) and to determine the contributions of budesonide and formoterol to those effects in adults with asthma. RESEARCH DE...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1185/030079908X273354

データ提供：米国国立医学図書館（NLM）

Asthma Treatment: A Breath of Fresh Air

Asthma, a chronic respiratory disease, affects millions worldwide. The search for effective treatments continues, with new combinations of medications offering hope for improved symptom control. This research focuses on the effects of a combination of budesonide and formoterol, delivered via a single pressurized metered-dose inhaler (budesonide/formoterol pMDI), on patient-reported outcomes in adults with mild-to-moderate persistent asthma. The authors provide a comprehensive overview of the study design, methodology, and findings, highlighting the potential benefits of this combined approach.

Budesonide/Formoterol: A Synergistic Approach to Asthma Management

This research explores the effectiveness of a combined approach using budesonide and formoterol, delivered via a single pressurized metered-dose inhaler (budesonide/formoterol pMDI), in the treatment of mild-to-moderate persistent asthma. The study demonstrates significant improvements in patient-reported outcomes, including asthma-related quality of life, quality of sleep, and asthma control. The authors highlight the synergistic effect of this combined approach, suggesting that it may offer a more effective treatment option for individuals with asthma.

Breathing Easier: A Guide to Asthma Management

This research provides valuable insights into the potential benefits of budesonide/formoterol pMDI in the management of asthma. The study highlights the positive impact of this combined approach on patient-reported outcomes, demonstrating its ability to improve asthma-related quality of life, quality of sleep, and asthma control. This research emphasizes the importance of finding a treatment approach that optimizes symptom control and enhances overall quality of life for individuals with asthma.

Dr. Camel's Conclusion

This study demonstrates the effectiveness of budesonide/formoterol pMDI in improving asthma-related quality of life, quality of sleep, and asthma control in adults with mild-to-moderate persistent asthma. This research underscores the potential benefits of this combined approach, offering a promising treatment option for individuals struggling with asthma.

Date :
  1. Date Completed 2008-06-13
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

18267051

DOI: Digital Object Identifier

10.1185/030079908X273354

Related Literature

Article Analysis
・Effects of budesonide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.